Cormorant Asset Management

company

Number of Investments

Number of Lead Investments

Cormorant Asset Management has made 21 investments. Their most recent investment was on Aug 12, 2022, when Greenlight Biosciences, Inc raised

Date	Company Name	Round	Money Raised	Industry	Lead Investor
Aug 12, 2022	Greenlight Biosciences	Post-IPO Equity	—	Agriculture	—
Apr 19, 2022	Tessera Therapeutics	Series C	—	Biopharma	—
Feb 16, 2022	Star Therapeutics	Series Unknown	—		—
Feb 3, 2022	Greenlight Biosciences	Post-IPO Equity	—	Agriculture	—
Jul 13, 2021	Prime Medicine	Series B	—	Biotechnology	—
Mar 22, 2021	EpimAb Biotherapeutics	Series C	—	Biopharma	—
Jan 19, 2021	Beam Therapeutics	Post-IPO Equity	—	Biotechnology	—
Jan 19, 2021	Verve Therapeutics	Series B	—	Biotechnology	—
Sep 28, 2020	BioShin	Series A	—	Biotechnology	—
Aug 26, 2020	Freenome	Series C	—	Biotechnology	—
Jun 16, 2020	Greenlight Biosciences	Series D	—	Agriculture	—
Nov 13, 2019	Avidity Biosciences	Series C	—	Biotechnology	—
Mar 6, 2019	Beam Therapeutics	Series B	—	Biotechnology	—
Apr 25, 2018	Corvidia	Series B	—	Biotechnology	—
Nov 16, 2017	X4 Pharmaceuticals	Series B	—	Biotechnology	Yes
Sep 26, 2017	Autolus	Series C	—	Biopharma	Yes
Sep 8, 2017	Replimune Group	Series B	—	Biotechnology	—
Jul 18, 2016	Ardelyx	Post-IPO Equity	—	Biotechnology	—
Jan 19, 2016	Twist Bioscience	Series D	—	Biotechnology	—
Dec 15, 2015	X4 Pharmaceuticals	Series A	—	Biotechnology	Yes
Jun 22, 2015	Ardelyx	Post-IPO Equity	—	Biotechnology	—